• Japan IVO

APASL 2016報告

25th Asian Pacific Association for the Study of the Liver(第25回アジア太平洋肝臓学会 APASL 2016)が2月20日(土)から24日(水)まで東京で開催されました。千葉大学の横須賀収教授がPresidentで、椎名教授は Scientific Committee の Chairman に任命されました。椎名教授はInvited speaker として2つの講演を行なった他、APASL HCC Guideline および Symposium 11: Update of HCC Treatmentのmodulatorを務め、また、Presidential Plenary Session およびParallel Oral Session で発表しました。また、畑中先生が4つ、清水先生が3つ、林先生、佐藤先生が各1つずつの演題を発表しました。内容は以下の通りです。 http://www.apasl2016.org/

  1. Shiina S. Post Graduate Course B, Local Treatment of HCC: RFA. APASL 2016, Tokyo, Japan, 2016/2/20

  2. Shiina S. Symposium11: Update of HCC Treatment, Local Treatment of HCC. APASL 2016, Tokyo, Japan, 2016/2/23

  3. Shiina S, Shimizu R, Taniki N, Hayashi M, Kanazawa R, Miura H, Sato K, Ishii S, Hatanaka T, Sai JK, Watanabe S. Presidential Plenary: Juntendo University Radiofrequency Ablation (RFA) Training Program. APASL 2016, Tokyo, Japan, 2016/2/22

  4. Shiina S, Shimizu R, Taniki N, Hayashi M, Kanazawa R, Miura H, Sato K, Ishii S, Hatanaka T, Sai JK, Watanabe S. International Radiofrequency Ablation (RFA) Training Program. APASL 2016, Tokyo, Japan, 2016/2/22

  5. Hatanaka T, Kakizaki S, Shimada Y, Takizawa D, Katakai K, Yamazaki Y, Sato K, Kusano M, Yamada M. Prediction of Response to Tansarterial Chemotherapy with CDDP Powder for Hepatocellular Carcinoma. APASL 2016, Tokyo, Japan, 2016/2/22

  6. Hatanaka T, Kakizaki S, Suzuki Y, Takeuchi S, Shimada Y, Takizawa D, Katakai K, Yamazaki Y, Sato K, Yamada M. Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Located in the Caudate Lobe. APASL 2016, Tokyo, Japan, 2016/2/22

  7. Hatanaka T, Shimizu R, Hayashi M, Taniki N, Kanazawa R, Sato K, Ishii S, Sai JK, Matsuoka K, Watanabe S, Shiina S. Factors Relevant to Incomplete Ablation at First Session of RFA in 403 HCC Patients. APASL 2016, Tokyo, Japan, 2016/2/23

  8. Hatanaka T, Kakizaki S, Suzuki Y, Shimada Y, Takizawa D, Katakai K, Sato K, Yamada M. Gastric Varices Successfully Treated by Shunt Occlusion-Endoscopic Injection Therapy: A Case Report. APASL 2016, Tokyo, Japan, 2016/2/23

  9. Shimizu R, Taniki N, Hayashi M, Kanazawa R, Miura H, Sato K, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Efficacy and Safety of Dual Oral Therapy with DCV and ASV after Curative RFA of HCV-Related HCC. APASL 2016, Tokyo, Japan, 2016/2/21

  10. Shimizu R, Taniki N, Hayashi M, Kanazawa R, Miura H, Sato K, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Radiofrequency Ablation in Very Elderly Patients (85 years old or older) with Liver Tumors. APASL 2016, Tokyo, Japan, 2016/2/22

  11. Shimizu R, Taniki N, Hayashi M, Kanazawa R, Miura H, Sato K, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Radiofrequency Ablation by New Adjustable Electrode: Initial Experience. APASL 2016, Tokyo, Japan, 2016/2/22

  12. Hayashi M, Shimizu R, Miura H, Kanazawa R, Sato K, Taniki N, Ishii S, Hatanaka T, Sai JK, Watanabe S, Shiina S. Frequency of Surgical Site Infection after RFA without Maximal Sterile Barrier Precautions. APASL 2016, Tokyo, Japan, 2016/2/22

  13. Sato K, Shimizu R, Hayashi M, Kanazawa R, Taniki N, Ishii S, Ito T, Saito H, Sai JK, Watanabe S, Shiina S. The Risk Factors for Percutaneous Radiofrequency Ablation under Monitored Anesthesia Care. APASL 2016, Tokyo, Japan, 2016/2/22

(写真はクリックすると拡大します)



0回の閲覧0件のコメント
  • Facebook
  • Twitter

©2020 by Japan Ablation Webinar.